These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15990293)

  • 21. Synthesis and biological studies of different duocarmycin based glycosidic prodrugs for their use in the antibody-directed enzyme prodrug therapy.
    Tietze LF; Schuster HJ; Krewer B; Schuberth I
    J Med Chem; 2009 Jan; 52(2):537-43. PubMed ID: 19143570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity.
    Shamis M; Barbas CF; Shabat D
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1172-5. PubMed ID: 17234408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of phenyl substituents on the release rates of esterase-sensitive coumarin-based prodrugs.
    Liao Y; Hendrata S; Bae SY; Wang B
    Chem Pharm Bull (Tokyo); 2000 Aug; 48(8):1138-47. PubMed ID: 10959577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and hydrolytic behavior of ibuprofen prodrugs and their PEGylated derivatives.
    Davaran S; Rashidi MR; Hanaee J; Hamidi AA; Hashemi M
    Drug Deliv; 2006; 13(5):383-7. PubMed ID: 16877314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design.
    Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P
    Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineoplastic agents 453. Synthesis of pancratistatin prodrugs.
    Pettit GR; Orr B; Ducki S
    Anticancer Drug Des; 2000 Dec; 15(6):389-95. PubMed ID: 11716431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating prodrug strategies for esterase-triggered release of alcohols.
    Perez C; Daniel KB; Cohen SM
    ChemMedChem; 2013 Oct; 8(10):1662-7. PubMed ID: 23929690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prodrug study of plinabulin using a click strategy focused on the effects of a replaceable water-solubilizing moiety.
    Yakushiji F; Tanaka H; Muguruma K; Iwahashi T; Yamazaki Y; Hayashi Y
    Chem Pharm Bull (Tokyo); 2012; 60(7):877-81. PubMed ID: 22790821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-hydroxybenzenecarboximidic acid derivatives: a new class of nitroxyl-generating prodrugs.
    Lee MJ; Shoeman DW; Goon DJ; Nagasawa HT
    Nitric Oxide; 2001 Jun; 5(3):278-87. PubMed ID: 11384201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycosyl and polyalcoholic prodrugs of lonidamine.
    Giorgioni G; Ruggieri S; Di Stefano A; Sozio P; Cinque B; Di Marzio L; Santoni G; Claudi F
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2445-50. PubMed ID: 18321702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penicillins as beta-lactamase-dependent prodrugs: enabling role of a vinyl ester exocyclic to the lactam ring.
    Ruddle CC; Smyth TP
    Chem Commun (Camb); 2004 Oct; (20):2332-3. PubMed ID: 15490006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of esterases involved in the hydrolysis of dipivefrin hydrochloride.
    Nakamura M; Shirasawa E; Hikida M
    Ophthalmic Res; 1993; 25(1):46-51. PubMed ID: 8446367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esterase-activated chromane-sydnonimine prodrug hybrids.
    Vinatier V; Soulère L; Hoffmann P
    Nitric Oxide; 2006 Dec; 15(4):363-9. PubMed ID: 16644247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acyloxymethyl acidic drug derivatives: in vitro hydrolytic reactivity.
    Redden PR; Melanson RL; Douglas JA; Dick AJ
    Int J Pharm; 1999 Apr; 180(2):151-60. PubMed ID: 10370185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esterase-sensitive sulfur dioxide prodrugs inspired by modified Julia olefination.
    Wang W; Wang B
    Chem Commun (Camb); 2017 Sep; 53(73):10124-10127. PubMed ID: 28840924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism.
    Biggadike K; Angell RM; Burgess CM; Farrell RM; Hancock AP; Harker AJ; Irving WR; Ioannou C; Procopiou PA; Shaw RE; Solanke YE; Singh OM; Snowden MA; Stubbs RJ; Walton S; Weston HE
    J Med Chem; 2000 Jan; 43(1):19-21. PubMed ID: 10633034
    [No Abstract]   [Full Text] [Related]  

  • 37. Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.
    Jones M; Inkielewicz I; Medina C; Santos-Martinez MJ; Radomski A; Radomski MW; Lally MN; Moriarty LM; Gaynor J; Carolan CG; Khan D; O'Byrne P; Harmon S; Holland V; Clancy JM; Gilmer JF
    J Med Chem; 2009 Nov; 52(21):6588-98. PubMed ID: 19821574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular trapping of cycloSal-pronucleotides: modification of prodrugs with amino acid esters.
    Jessen HJ; Balzarini J; Meier C
    J Med Chem; 2008 Oct; 51(20):6592-8. PubMed ID: 18826203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substituted coumarins as esterase-sensitive prodrug moieties with improved release rates.
    Liao Y; Wang B
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1795-800. PubMed ID: 10406644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of a NO-releasing prodrug of rofecoxib.
    Engelhardt FC; Shi YJ; Cowden CJ; Conlon DA; Pipik B; Zhou G; McNamara JM; Dolling UH
    J Org Chem; 2006 Jan; 71(2):480-91. PubMed ID: 16408954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.